These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 33356420

  • 1. Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study.
    Hellesnes R, Myklebust TÅ, Bremnes RM, Karlsdottir Á, Kvammen Ø, Negaard HFS, Tandstad T, Wilsgaard T, Fosså SD, Haugnes HS.
    J Clin Oncol; 2021 Feb 01; 39(4):308-318. PubMed ID: 33356420
    [Abstract] [Full Text] [Related]

  • 2. Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular Cancer.
    Blok JM, Groot HJ, Huele EH, de Wit R, Horenblas S, Nuver J, Groenewegen G, Bosch JLHR, Witjes JA, Tromp JM, de Brouwer PJM, van den Berg HA, Vanneste BGL, Smilde TJ, Aarts MJB, Gietema JA, Meijer RP, Schaapveld M.
    J Clin Oncol; 2021 Feb 01; 39(4):319-327. PubMed ID: 33119475
    [Abstract] [Full Text] [Related]

  • 3. Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7,102 Norwegian patients (1953-2007).
    Andreassen KE, Grotmol T, Cvancarova MS, Johannesen TB, Fosså SD.
    Int J Cancer; 2011 Dec 15; 129(12):2867-74. PubMed ID: 21626506
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.
    Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB.
    J Clin Oncol; 2013 Oct 20; 31(30):3807-14. PubMed ID: 24043737
    [Abstract] [Full Text] [Related]

  • 6. Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort.
    Hellesnes R, Myklebust TÅ, Fosså SD, Bremnes RM, Karlsdottir Á, Kvammen Ø, Tandstad T, Wilsgaard T, Negaard HFS, Haugnes HS.
    J Clin Oncol; 2021 Nov 10; 39(32):3561-3573. PubMed ID: 34388002
    [Abstract] [Full Text] [Related]

  • 7. Incidence and clinical pattern of contralateral synchronous and metachronous germ cell testicular cancer.
    Maroto P, García Del Muro X, Valverde C, Pinto A, Sanchez A, Guma J, Alonso T, Martínez Del Prado P, Vazquez S, Mellado B, Aparicio J, Fernandez-Aramburo A, Girones R, Terrasa J, Spanish Germ Cell Cancer Group.
    Urol Oncol; 2021 Feb 10; 39(2):135.e17-135.e23. PubMed ID: 33189529
    [Abstract] [Full Text] [Related]

  • 8. Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis.
    Li H, Zhu C, Wu J, Ma Y, Jin X, Wei X, Wang K, Li H.
    Int Urol Nephrol; 2021 Mar 10; 53(3):471-477. PubMed ID: 33052518
    [Abstract] [Full Text] [Related]

  • 9. Risk and prognostic significance of metachronous contralateral testicular germ cell tumours.
    Schaapveld M, van den Belt-Dusebout AW, Gietema JA, de Wit R, Horenblas S, Witjes JA, Hoekstra HJ, Kiemeney LA, Louwman WJ, Ouwens GM, Aleman BM, van Leeuwen FE.
    Br J Cancer; 2012 Oct 23; 107(9):1637-43. PubMed ID: 23059747
    [Abstract] [Full Text] [Related]

  • 10. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW, de Wit R, Gietema JA, Horenblas S, Louwman MW, Ribot JG, Hoekstra HJ, Ouwens GM, Aleman BM, van Leeuwen FE.
    J Clin Oncol; 2007 Oct 01; 25(28):4370-8. PubMed ID: 17906202
    [Abstract] [Full Text] [Related]

  • 11. Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.
    Groot HJ, Lubberts S, de Wit R, Witjes JA, Kerst JM, de Jong IJ, Groenewegen G, van den Eertwegh AJM, Poortmans PM, Klümpen HJ, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, Incrocci L, van den Bergh ACM, Jóźwiak K, van den Belt-Dusebout AW, Horenblas S, Gietema JA, van Leeuwen FE, Schaapveld M.
    J Clin Oncol; 2018 Aug 20; 36(24):2504-2513. PubMed ID: 29989856
    [Abstract] [Full Text] [Related]

  • 12. Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients.
    Inoue Y, Nakamura T, Nakanishi H, Oishi M, Hongo F, Okihara K, Mizutani S, Kuroda J, Ukimura O.
    Int J Urol; 2018 Jul 20; 25(7):678-683. PubMed ID: 29752743
    [Abstract] [Full Text] [Related]

  • 13. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009).
    Solheim O, Kærn J, Tropé CG, Rokkones E, Dahl AA, Nesland JM, Fosså SD.
    Gynecol Oncol; 2013 Nov 20; 131(2):330-5. PubMed ID: 24001518
    [Abstract] [Full Text] [Related]

  • 14. Platinum exposure and cause-specific mortality among patients with testicular cancer.
    Groot HJ, van Leeuwen FE, Lubberts S, Horenblas S, de Wit R, Witjes JA, Groenewegen G, Poortmans PM, Hulshof MCCM, Meijer OWM, de Jong IJ, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJB, Jóźwiak K, van den Belt-Dusebout AW, Gietema JA, Schaapveld M.
    Cancer; 2020 Feb 01; 126(3):628-639. PubMed ID: 31730712
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dose-dense chemotherapy for untreated poor-prognosis and relapsed germ-cell tumours: an 18-year experience with GAMEC chemotherapy.
    Shamash J, Mee M, Sarker SJ, Wilson P, Ansell W, Greenwood M, Berney D, Alifrangis C.
    BJU Int; 2020 Jun 01; 125(6):843-852. PubMed ID: 31688976
    [Abstract] [Full Text] [Related]

  • 18. Second Malignant Neoplasms and Cause of Death in Patients With Germ Cell Cancer: A Danish Nationwide Cohort Study.
    Kier MG, Hansen MK, Lauritsen J, Mortensen MS, Bandak M, Agerbaek M, Holm NV, Dalton SO, Andersen KK, Johansen C, Daugaard G.
    JAMA Oncol; 2016 Dec 01; 2(12):1624-1627. PubMed ID: 27711914
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
    Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, Wilsgaard T, Bremnes RM, Fosså SD.
    J Clin Oncol; 2010 Oct 20; 28(30):4649-57. PubMed ID: 20855830
    [Abstract] [Full Text] [Related]

  • 20. Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer.
    Brabrand S, Fosså SD, Cvancarova M, Axcrona U, Lehne G.
    J Clin Oncol; 2012 Nov 10; 30(32):4004-10. PubMed ID: 23071246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.